Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2

Anne Vest Sørensen; Gregers G Hermann; Niels Jensen; Astrid Petersen; Niels Henrik Spliid; Rickard Sandin; Kirsten Fode; Poul F Geertsen

doi:10.1016/j.ejca.2013.10.010

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2

Anne Vest Sørensen, Gregers G Hermann, Niels Jensen, Astrid Petersen, Niels Henrik Spliid, Rickard Sandin, Kirsten Fode, Poul F Geertsen

Afdeling for Kræftbehandling HGH

71 Citationer (Scopus)

Abstract

To evaluate the implementation of targeted therapy on overall survival (OS) in a complete national cohort of patients with metastatic renal cell carcinoma (mRCC).

Originalsprog	Engelsk
Tidsskrift	European journal of cancer (Oxford, England : 1990)
Vol/bind	50
Udgave nummer	3
Sider (fra-til)	553-62
Antal sider	10
ISSN	0959-8049
DOI	https://doi.org/10.1016/j.ejca.2013.10.010
Status	Udgivet - feb. 2014

Adgang til dokumentet

10.1016/j.ejca.2013.10.010

Citationsformater

Sørensen, A. V., Hermann, G. G., Jensen, N., Petersen, A., Spliid, N. H., Sandin, R., Fode, K., & Geertsen, P. F. (2014). Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2. European journal of cancer (Oxford, England : 1990), 50(3), 553-62. https://doi.org/10.1016/j.ejca.2013.10.010

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2. / Sørensen, Anne Vest; Hermann, Gregers G; Jensen, Niels et al.
I: European journal of cancer (Oxford, England : 1990), Bind 50, Nr. 3, 02.2014, s. 553-62.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Sørensen, AV, Hermann, GG, Jensen, N, Petersen, A, Spliid, NH, Sandin, R, Fode, K & Geertsen, PF 2014, 'Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2', European journal of cancer (Oxford, England : 1990), bind 50, nr. 3, s. 553-62. https://doi.org/10.1016/j.ejca.2013.10.010

@article{1c038adc1c8642f186385789c92e8397,

title = "Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2",

abstract = "To evaluate the implementation of targeted therapy on overall survival (OS) in a complete national cohort of patients with metastatic renal cell carcinoma (mRCC).",

author = "S{\o}rensen, {Anne Vest} and Hermann, {Gregers G} and Niels Jensen and Astrid Petersen and Spliid, {Niels Henrik} and Rickard Sandin and Kirsten Fode and Geertsen, {Poul F}",

year = "2014",

month = feb,

doi = "10.1016/j.ejca.2013.10.010",

language = "English",

volume = "50",

pages = "553--62",

journal = "European journal of cancer (Oxford, England : 1990)",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "3",

}

TY - JOUR

T1 - Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma

T2 - Results from the Danish Renal Cancer Group (DARENCA) study-2

AU - Sørensen, Anne Vest

AU - Hermann, Gregers G

AU - Jensen, Niels

AU - Petersen, Astrid

AU - Spliid, Niels Henrik

AU - Sandin, Rickard

AU - Fode, Kirsten

AU - Geertsen, Poul F

PY - 2014/2

Y1 - 2014/2

N2 - To evaluate the implementation of targeted therapy on overall survival (OS) in a complete national cohort of patients with metastatic renal cell carcinoma (mRCC).

AB - To evaluate the implementation of targeted therapy on overall survival (OS) in a complete national cohort of patients with metastatic renal cell carcinoma (mRCC).

U2 - 10.1016/j.ejca.2013.10.010

DO - 10.1016/j.ejca.2013.10.010

M3 - Journal article

C2 - 24215846

SN - 0959-8049

VL - 50

SP - 553

EP - 562

JO - European journal of cancer (Oxford, England : 1990)

JF - European journal of cancer (Oxford, England : 1990)

IS - 3

ER -

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater